These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16309904)

  • 1. Design, synthesis, and biological evaluation of BODIPY-erythromycin probes for bacterial ribosomes.
    Li J; Kim IH; Roche ED; Beeman D; Lynch AS; Ding CZ; Ma Z
    Bioorg Med Chem Lett; 2006 Feb; 16(4):794-7. PubMed ID: 16309904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unnatural rigid scaffolds targeting the bacterial ribosome.
    Katsoulis IA; Pyrkotis C; Papakyriakou A; Kythreoti G; Zografos AL; Mavridis I; Nahmias VR; Anastasopoulou P; Vourloumis D
    Chembiochem; 2009 Aug; 10(12):1969-72. PubMed ID: 19585638
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorescence polarization method to characterize macrolide-ribosome interactions.
    Yan K; Hunt E; Berge J; May E; Copeland RA; Gontarek RR
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3367-72. PubMed ID: 16048949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
    Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
    J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity.
    Dreier I; Kumar S; Søndergaard H; Rasmussen ML; Hansen LH; List NH; Kongsted J; Vester B; Nielsen P
    J Med Chem; 2012 Mar; 55(5):2067-77. PubMed ID: 22280300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HSP60 as a primary target of o-carboranylphenoxyacetanilide, an HIF-1alpha inhibitor.
    Ban HS; Shimizu K; Minegishi H; Nakamura H
    J Am Chem Soc; 2010 Sep; 132(34):11870-1. PubMed ID: 20695501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of cyclic 2',3'-carbamate derivatives of erythromycin macrolide antibiotics.
    Heggelund A; Undheim K
    Bioorg Med Chem; 2007 May; 15(9):3266-77. PubMed ID: 17337343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
    Chittum HS; Champney WS
    Curr Microbiol; 1995 May; 30(5):273-9. PubMed ID: 7766155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans.
    Jabbour A; Steinberg D; Dembitsky VM; Moussaieff A; Zaks B; Srebnik M
    J Med Chem; 2004 May; 47(10):2409-10. PubMed ID: 15115381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
    Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
    Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro].
    Xu P; Yang Y; Shi Y; Lei PS; Liu L
    Yao Xue Xue Bao; 2007 May; 42(5):497-501. PubMed ID: 17703771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
    Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 9-deoxo-4''-deoxy-6,9-epoxyerythromycin derivatives: novel and acid-stable motilides.
    Faghih R; Lartey PA; Nellans HN; Seif L; Burnell-Curty C; Klein LL; Thomas P; Petersen A; Borre A; Pagano T; Kim KH; Heindel M; Bennani YL; Plattner JJ
    J Med Chem; 1998 Aug; 41(18):3402-8. PubMed ID: 9719592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome.
    Seefeldt AC; Graf M; Pérébaskine N; Nguyen F; Arenz S; Mardirossian M; Scocchi M; Wilson DN; Innis CA
    Nucleic Acids Res; 2016 Mar; 44(5):2429-38. PubMed ID: 26792896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance studies on the mode of action of erythromycin A.
    Gyi JI; Barber J
    Biochem Soc Trans; 1991 Aug; 19(3):313S. PubMed ID: 1783149
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells.
    Usary J; Champney WS
    Mol Microbiol; 2001 May; 40(4):951-62. PubMed ID: 11401702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving on nature: antibiotics that target the ribosome.
    Sutcliffe JA
    Curr Opin Microbiol; 2005 Oct; 8(5):534-42. PubMed ID: 16111914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
    Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
    ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of [14C]chloramphenicol binding to Escherichia coli ribosomes by erythromycin derivatives.
    Pestka S; LeMahieu RA
    Antimicrob Agents Chemother; 1974 Jul; 6(1):39-45. PubMed ID: 15828169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abiotic strategy for the enantioselective synthesis of erythromycin B.
    Hergenrother PJ; Hodgson A; Judd AS; Lee WC; Martin SF
    Angew Chem Int Ed Engl; 2003 Jul; 42(28):3278-81. PubMed ID: 12876743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.